论文部分内容阅读
为探讨不同类型病毒性肝炎骨密度的变化及影响因素.应用SD-1000型骨矿分析仪测量左侧桡尺骨骨密度。与正常对照组比较,急性肝炎骨密度无明量降低(P>0.05).慢性肝炎,肝炎肝硬变骨密度明显降低,后者更显著(P<0.01)。慢性肝病病程≥10年较病程<10年者.骨密度明显降低(P<0.05);肝炎肝硬变血清白蛋白<30g/L较血消白蛋白≥30g/L者.骨密度明显降低(P<0.01)。结论:慢性肝病患者骨密度降低。骨密度检测可作为问接衡量肝病严重程度的指标。
To explore the changes of bone mineral density and its influencing factors in different types of viral hepatitis, the bone mineral density of left ulna was measured by SD-1000 bone mineral analyzer. Compared with the normal control group, there was no obvious decrease in BMD of acute hepatitis (P> 0.05), and the bone density of chronic hepatitis and hepatitis cirrhosis decreased significantly (P <0.01). Bone densities were significantly lower in patients with chronic liver disease than in those with disease duration less than 10 years and less than 10 years (P <0.05); those with cirrhosis of liver cirrhosis <30g / L were more severe than those with serum albumin ≥30g / P <0.01). Conclusion: Bone mineral density decreased in patients with chronic liver disease. Bone mineral density testing can be used as a measure of the severity of liver disease.